2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors
作者:Kenji Fukunaga、Fumiaki Uehara、Keiichi Aritomo、Aya Shoda、Shinsuke Hiki、Masahiro Okuyama、Yoshihiro Usui、Kazutoshi Watanabe、Koichi Yamakoshi、Toshiyuki Kohara、Tokushi Hanano、Hiroshi Tanaka、Susumu Tsuchiya、Shinji Sunada、Ken-Ichi Saito、Jun-ichi Eguchi、Satoshi Yuki、Shoichi Asano、Shinji Tanaka、Akiko Mori、Keiji Yamagami、Hiroshi Baba、Takashi Horikawa、Masatake Fujimura
DOI:10.1016/j.bmcl.2013.09.020
日期:2013.12
A series of 2-(2-phenylmorpholin-4-yl)pyrimidin-4(3H)-ones was synthesized and examined for their inhibitory activity against glycogen synthase kinase-3β (GSK-3β). We found 21, 29 and 30 to possess potent in vitro GSK-3β inhibitory activity with good in vitro PK profiles. 21 demonstrated significant decrease of tau phosphorylation after oral administration in mice and excellent PK profiles.
合成了一系列2-(2-苯基吗啉-4-基)嘧啶-4(3 H)-酮,并检查了它们对糖原合酶激酶-3β(GSK-3β)的抑制活性。我们发现21,29和30,以在体外具有GSK-3β在体外PK性能良好的抑制活性有效。21显示在小鼠口服后tau磷酸化显着降低,PK表现出色。